PT3139948T - Treatment of diabetes type 1 using glp-1 and anti-il-21 - Google Patents
Treatment of diabetes type 1 using glp-1 and anti-il-21Info
- Publication number
- PT3139948T PT3139948T PT157209826T PT15720982T PT3139948T PT 3139948 T PT3139948 T PT 3139948T PT 157209826 T PT157209826 T PT 157209826T PT 15720982 T PT15720982 T PT 15720982T PT 3139948 T PT3139948 T PT 3139948T
- Authority
- PT
- Portugal
- Prior art keywords
- glp
- treatment
- diabetes type
- diabetes
- type
- Prior art date
Links
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461989841P | 2014-05-07 | 2014-05-07 | |
| EP14169596 | 2014-05-23 | ||
| EP14189732 | 2014-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3139948T true PT3139948T (en) | 2020-05-22 |
Family
ID=70609983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157209826T PT3139948T (en) | 2014-05-07 | 2015-05-05 | Treatment of diabetes type 1 using glp-1 and anti-il-21 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP6824373B2 (en) |
| DK (1) | DK3139948T3 (en) |
| ES (1) | ES2791879T3 (en) |
| HR (1) | HRP20200763T1 (en) |
| HU (1) | HUE048860T2 (en) |
| PT (1) | PT3139948T (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI9711437B8 (en) * | 1996-08-30 | 2021-05-25 | Novo Nordisk As | glp-1 derivatives |
| WO2005023291A2 (en) * | 2003-09-11 | 2005-03-17 | Novo Nordisk A/S | Use of glp1-agonists in the treatment of patients with type i diabetes |
| EP3103813A1 (en) * | 2007-12-07 | 2016-12-14 | ZymoGenetics, Inc. | Anti-human il-21 monoclonal antibodies |
| CN103702721A (en) * | 2011-05-31 | 2014-04-02 | 诺沃—诺迪斯克有限公司 | IL-21 epitope and IL-21 ligands |
-
2015
- 2015-05-05 PT PT157209826T patent/PT3139948T/en unknown
- 2015-05-05 DK DK15720982.6T patent/DK3139948T3/en active
- 2015-05-05 HR HRP20200763TT patent/HRP20200763T1/en unknown
- 2015-05-05 HU HUE15720982A patent/HUE048860T2/en unknown
- 2015-05-05 ES ES15720982T patent/ES2791879T3/en active Active
-
2019
- 2019-12-19 JP JP2019229235A patent/JP6824373B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE048860T2 (en) | 2020-09-28 |
| HRP20200763T1 (en) | 2020-07-24 |
| JP2020073501A (en) | 2020-05-14 |
| DK3139948T3 (en) | 2020-05-25 |
| ES2791879T3 (en) | 2020-11-06 |
| JP6824373B2 (en) | 2021-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3105213T3 (en) | Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| ZA201806637B (en) | Glucagon and glp-1 co-agonists for the treatment of obesity | |
| IL246757B (en) | Novel insulin derivatives and the medical uses hereof | |
| SI3297653T1 (en) | Treatment of post-bariatric hypoglycemia with glp-1 antagonists | |
| ZA201608281B (en) | Ppar compounds for use in the treatment of fibrotic diseases. | |
| IL283335B (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| IL254496A0 (en) | Treatment type 2 diabetes mellitus patients | |
| GB201707207D0 (en) | Treatment of type 1 diabetes | |
| IL254500A0 (en) | Treatment of type 2 diabetes mellitus patients | |
| IL252899A0 (en) | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | |
| PL3139948T3 (en) | Treatment of diabetes type 1 using glp-1 and anti-il-21 | |
| GB201403996D0 (en) | Traditional chinese medicine composition for the treatment of diabetes | |
| IL250666A0 (en) | Peptide for treatment of type 2 diabetes mellitus and its complications | |
| GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
| HUE048860T2 (en) | Treatment of diabetes type 1 using glp-1 and anti-il-21 | |
| GB201418541D0 (en) | Materials for use with general hyperthermia treatment | |
| SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes | |
| GB201417777D0 (en) | Novel compounds and therapeutic uses thereof | |
| ZA201404780B (en) | Composition for use in treatment of diabetes | |
| GB201410387D0 (en) | Compounds and their therapeutic use | |
| GB201403496D0 (en) | Compounds and their therapeutic use |